Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.
- Chamber
- House
- Introduced
- Aug 13, 2025
- Last action
- Mar 31, 2026 — PRINT NUMBER 9002A
- Session
- 2025-2026
- Momentum
- 44 · Moderate